Berberine inhibits the progression of breast cancer by regulating METTL3 ‐mediated m6A modification of FGF7 mRNA

ConclusionBBR treatment blocked breast cancer cell growth and metastasis partly by regulating METTL3-mediated m6A modification of FGF7 mRNA, providing a promising therapeutic target for breast cancer treatment.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Tags: ORIGINAL ARTICLE Source Type: research